arrow
S

Sergio Lo Caputo

University of Foggia
H指数:35
被引数:5,375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical management of pregnancy, delivery and breastfeeding in women living with HIV in Italy: A survey of participating infectious diseases centres

意大利HIV感染者妊娠期、分娩期及哺乳期临床管理:参与性传染病中心的调查

2026-09-150
PRE
Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

在意大利,HIV感染者抗逆转录病毒治疗启动时的肥胖与心血管疾病、癌症或死亡的长期风险:一项前瞻性队列研究

2026-08-010
PRE
Real-world evaluation of HIV-1 reservoir and resistance in virologically suppressed people after 52 weeks of treatment with long-acting cabotegravir plus rilpivirine

长期卡博格韦与 rilpivirine 联合治疗52周后病毒学抑制者中HIV-1储库和耐药性的真实世界评估

2026-07-010
PRE
Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres

在意大利HIV感染者中实施国家疫苗接种计划:ICONA中心调查

2026-04-010
PRE
The Forgotten Test: Missed Opportunities for HIV Diagnosis and Survival Outcomes in Advanced HIV Disease

被遗忘的检测:晚期HIV疾病中HIV诊断错失机会与生存结局

Viruses
IF3.5
2026-03-150
OAAI
Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study

卡博格韦–利匹韦林在PLWH中的疗效与安全性:一项真实世界研究

Viruses
IF3.5
2026-03-030
OAAI
Symptomatic (STB) and Asymptomatic (ATB) tuberculosis in Italy: Results from a multicenter retrospective study

症状性(STB)与非症状性(ATB)结核病在意大利:一项多中心回顾性研究的结果

2025-12-010
OAAI
Long-term trajectories of Hepatic and Metabolic biomarkers after switching from TDF to TAF in ART-Experienced PWH with and without Hepatic Coinfection: Data from the ICONA Cohort

从TDF转换为TAF后,在伴有和不伴有肝共感染的经治人类免疫缺陷病毒感染者中,肝脏和代谢生物标志物的长期变化轨迹:ICONA队列研究数据

2025-10-040
OAAI
Antiretroviral Adherence and Use of Antihypertensives, Statins, and Antidiabetics Among Elderly People with HIV: A 5-Year Real-World Study in Southern Italy

抗逆转录病毒依从性及抗高血压药物、他汀类药物和抗糖尿病药物在老年HIV患者中的使用:意大利南部一项为期5年的真实世界研究

2025-09-050
OA
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort

HIV感染者中一线拉米夫定/多替拉韦抗逆转录病毒疗法的有效性:ICONA基金会队列的真实世界数据

2025-09-010
PRE
Team-based, hybrid, or standard of care? Organizational models of tuberculosis care on tuberculosis outcomes in eleven Italian hospital

团队为基础、混合型或标准护理?意大利11家医院结核病护理的组织模式对结核病结局的影响

2025-08-260
OAAI
Comparison of diagnostic performances of HDV RNA quantification assays used in clinical practice: results from a national quality control multicenter study

临床实践中HDV RNA定量检测方法的诊断性能比较:一项国家质量控制多中心研究的结果

2025-08-060
OAAI
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era

CXCR4嗜性病毒在四类药物耐药HIV感染者中的持续存在及其在现代抗逆转录病毒治疗时代的临床影响

2025-07-010
PRE
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulation

达芦那韦组与利托那韦增强型达芦那韦组在晚期HIV患者中的三联一线方案有效性比较:一项试验模拟研究

2025-06-010
OAAI
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors

抗逆转录病毒治疗初治个体中,低频整合酶链转移抑制剂耐药突变对病毒学结局的影响

2025-04-100
OA
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases

ORCHESTRA Delphi共识:类风湿性疾病患者中SARS-CoV-2感染的诊断和治疗管理

2025-03-040
PRE